SEC Form 4 · accession 0001179110-15-016802
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jamie Mark Grooms
Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1,F2 | $5.09 | Dec 28, 2015 | A | 15,000 | A | — | Dec 29, 2015 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in four equal quarterly installments beginning on March 31, 2016, becoming fully vested on December 31, 2016.
- F2The option is not exercisable until such time as the number of shares reserved for issuance under the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated, have been increased by an affirmative vote of the shareholders of AxoGen, Inc. in an amount that exceeds the shares of Common Stock issuable upon exercise of the option and all other options containing this provision granted prior to such shareholder vote.